{
  "retracted": false,
  "timestamp": 1573171200000,
  "updates": [
    {
      "timestamp": 1573227718991,
      "identifier": {
        "doi": "10.1007/s00280-019-03984-2"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00280-019-03790-w"
  },
  "journal": "Cancer Chemotherapy and Pharmacology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation"
}
